Join Global Nutricia Metabolics Webinar 26th April

As part of our ongoing commitment to provide high quality scientific education to support healthcare professionals, Global Nutricia Metabolics releases the third in a series of webinars focusing on rare inherited metabolic disorders beyond PKU on Wednesday 26th April 17:30 -19:00 CEST.

harry
tyrosinemia-spotlight

Management of Tyrosinemia

International expert speakers will share the latest insights into the management of tyrosinemia. Join them and participate in a live question and answers sessions. A parent will also share their experience of the journey with a child diagnosed with tyrosinemia from diagnosis to school age.

This Global Nutricia Metabolics Webinar is intended for healthcare professionals only.

Register here
PROGRAM
17:30-18:00 CEST

Introduction to and overview of the Management of Tyrosenemia

Presented by Dr Corinne Da Laet, Head of Clinic for Metabolic Diseases, Queen Fabiola Childrens University Hospital, Brussels, Belgium
18:00-18:30 CEST

Overview of the Principles of Dietary Management with Case Study Examples

Presented by Uta Meyer, Metabolic Dietitian, Hanover Medical School, Germany
18:30-18:40

Parental experience
18:40-19:00

Live interactive Q&A with our speakers
Dr Corinne Da Laet

Dr Corinne Da Laet, Consultant Paediatrician in Nutrition and Metabolism, Brussels, Belgium

Uta Meyer

Uta Meyer, Metabolic Dietitian, Hanover, Germany

Register here
Tyrosinemia is a rare inherited disorder of protein metabolism that occurs in just 1 in 100,000 newborns worldwide


Contact

Please email: clare.szwec@danone.com for any questions.

Metabolism happy children sofa

Inherited Metabolic Disorders

Inherited metabolic disorders (IMDs), also known as Inborn errors of metabolism (IEM) are a group of rare disorders caused by genetic defects.

Find out more
nutricia-PKU-BH4-graphical-abstract

Learn more about latest research

News article about recent systematic review and meta-analysis exploring why protein substitutes are still very relevant to patients with PKU on BH4 treatment.

Find out more